Association of increased levels of MCP-1 and cathepsin-D in young onset type 2 diabetes patients (T2DM-Y) with severity of diabetic retinopathy

作者：Reddy Sruthi; Amutha Anandakumar; Rajalakshmi Ramachandran; Bhaskaran Regin; Monickaraj Finny; Rangasamy Sampathkumar; Anjana Ranjit Mohan; Abhijit Shiny; Gokulakrishnan Kuppan; Das Arup; Mohan Viswanathan; Balasubramanyam Muthuswamy

来源：Journal of Diabetes and Its Complications, 2017, 31(5): 804-809.

DOI：10.1016/j.jdiacomp.2017.02.017

• MCP-1
• Cathepsin-D
• T2DM-Y
• Diabetic Retinopathy
• Biomarkers

Aim: Young onset type 2 diabetes patients (T2DM-Y) have been shown to possess an increased risk of developing microvascular complications particularly diabetic retinopathy. However, the molecular mechanisms are not clearly understood. In this study, we investigated the serum levels of monocyte chemotactic protein 1 (MCP-1) and cathepsin-D in patients with T2DM-Y without and with diabetic retinopathy.
Methods: In this case-control study, participants comprised individuals with normal glucose tolerance (NGT = 40), patients with type 2 diabetes mellitus (T2DM = 35), non-proliferative diabetic retinopathy (NPDR = 35) and proliferative diabetic retinopathy (PDR = 35). Clinical characterization of the study subjects was done by standard procedures and MCP-1 and cathepsin-D were measured by ELISA.
Results: Compared to control individuals, patients with T2DM-Y, NPDR and PDR exhibited significantly (p < 0.001) higher levels of MCP-1. Cathepsin-D levels were also significantly (p < 0.001) higher in patients with T2DM-Y without and with diabetic retinopathy. Correlation analysis revealed a positive association (p < 0.001) between MCP-1 and cathepsin-D levels. There was also a significant negative correlation of MCP1/cathepsin-D with C-peptide levels. The association of increased levels of MCP-1/cathepsin-D in patients with DR persisted even after adjusting for all the confounding factors.
Conclusion: As both MCP-1 and cathepsin-D are molecular signatures of cellular senescence, we suggest that these biomarkers might be useful to predict the development of retinopathy in T2DM-Y patients.

• 出版日期2017-5